Fidelis Capital Partners LLC Acquires 164 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Fidelis Capital Partners LLC lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 6.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,855 shares of the medical device company’s stock after purchasing an additional 164 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Cooper Companies were worth $301,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in COO. Vanguard Group Inc. lifted its position in shares of Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after purchasing an additional 17,367,502 shares in the last quarter. Capital World Investors lifted its position in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC raised its position in Cooper Companies by 279.8% during the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares in the last quarter. Bessemer Group Inc. raised its position in Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock worth $203,013,000 after acquiring an additional 1,507,049 shares in the last quarter. Finally, Swedbank AB bought a new stake in Cooper Companies during the first quarter worth $139,246,000. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of several analyst reports. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler upped their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Robert W. Baird upped their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Finally, Wells Fargo & Company upped their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Trading Up 0.6 %

COO stock opened at $105.20 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The company’s 50-day simple moving average is $106.34 and its 200 day simple moving average is $96.91. The Cooper Companies, Inc. has a 52 week low of $77.01 and a 52 week high of $112.38. The company has a market capitalization of $20.95 billion, a PE ratio of 58.44, a price-to-earnings-growth ratio of 2.53 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. During the same period in the prior year, the company posted $0.84 earnings per share. Cooper Companies’s revenue was up 7.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Insider Activity at Cooper Companies

In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Albert G. White III sold 114,992 shares of the stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 256,373 shares of company stock worth $27,637,427. Corporate insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.